2015 Q1 Form 10-Q Financial Statement

#000143774915002331 Filed on February 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $26.10M $23.74M $24.00M
YoY Change 8.75% 15.15% 1.69%
Cost Of Revenue $19.30M $17.12M $17.70M
YoY Change 9.04% 16.71% 1.14%
Gross Profit $6.800M $6.628M $6.400M
YoY Change 6.25% 11.32% 4.92%
Gross Profit Margin 26.05% 27.92% 26.67%
Selling, General & Admin $3.100M $3.100M $2.700M
YoY Change 14.81% 10.71% -6.9%
% of Gross Profit 45.59% 46.77% 42.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $260.0K $260.0K $270.0K
YoY Change -3.7% -3.7% 3.85%
% of Gross Profit 3.82% 3.92% 4.22%
Operating Expenses $3.300M $3.300M $2.800M
YoY Change 17.86% 10.0% -9.68%
Operating Profit $3.500M $3.272M $3.600M
YoY Change -2.78% 14.45% 20.0%
Interest Expense -$100.0K $10.00K $0.00
YoY Change 25.0%
% of Operating Profit -2.86% 0.31% 0.0%
Other Income/Expense, Net $0.00 -$3.000K $0.00
YoY Change -123.08%
Pretax Income $3.500M $3.242M $3.300M
YoY Change 6.06% 13.0% 13.79%
Income Tax $1.300M $1.196M $1.300M
% Of Pretax Income 37.14% 36.89% 39.39%
Net Earnings $2.100M $2.046M $2.000M
YoY Change 5.0% 15.01% 5.26%
Net Earnings / Revenue 8.05% 8.62% 8.33%
Basic Earnings Per Share $0.20
Diluted Earnings Per Share $207.9K $0.20 $202.0K
COMMON SHARES
Basic Shares Outstanding 10.06M 10.07M
Diluted Shares Outstanding 10.10M

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.800M $500.0K $600.0K
YoY Change 200.0% -86.84% 100.0%
Cash & Equivalents $1.807M $485.0K $560.0K
Short-Term Investments
Other Short-Term Assets $2.900M $3.900M $2.200M
YoY Change 31.82% 39.29% -4.35%
Inventory $15.47M $19.30M $13.61M
Prepaid Expenses $1.906M $3.156M $1.391M
Receivables $22.40M $2.583M $912.0K
Other Receivables $807.0K $2.600M $912.0K
Total Short-Term Assets $42.52M $45.50M $38.07M
YoY Change 11.69% 10.44% 8.15%
LONG-TERM ASSETS
Property, Plant & Equipment $528.0K $578.0K $586.0K
YoY Change -9.9% -3.67% -16.29%
Goodwill $1.126M $1.126M $1.126M
YoY Change 0.0%
Intangibles $4.507M $4.689M $5.248M
YoY Change -14.12%
Long-Term Investments
YoY Change
Other Assets $133.0K $133.0K $77.00K
YoY Change 72.73% -87.91% -93.0%
Total Long-Term Assets $7.427M $7.598M $8.146M
YoY Change -8.83% -7.34% -9.49%
TOTAL ASSETS
Total Short-Term Assets $42.52M $45.50M $38.07M
Total Long-Term Assets $7.427M $7.598M $8.146M
Total Assets $49.95M $53.10M $46.22M
YoY Change 8.07% 7.49% 4.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.472M $9.309M $5.066M
YoY Change -11.73% -3.03% -31.54%
Accrued Expenses $4.100M $4.300M $3.700M
YoY Change 10.81% 10.26% 48.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.37M $15.06M $10.30M
YoY Change 0.74% 1.75% -9.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.37M $15.06M $10.30M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $10.40M $15.10M $10.30M
YoY Change 0.97% 2.03% -9.65%
SHAREHOLDERS EQUITY
Retained Earnings -$719.0K -$2.052M -$3.216M
YoY Change -77.64%
Common Stock $48.68M $48.41M $47.28M
YoY Change 2.96%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390M $8.320M $8.147M
YoY Change 2.98%
Treasury Stock Shares $1.965M $1.957M $1.933M
Shareholders Equity $39.57M $38.04M $35.92M
YoY Change
Total Liabilities & Shareholders Equity $49.95M $53.10M $46.22M
YoY Change 8.07% 7.49% 4.56%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income $2.100M $2.046M $2.000M
YoY Change 5.0% 15.01% 5.26%
Depreciation, Depletion And Amortization $260.0K $260.0K $270.0K
YoY Change -3.7% -3.7% 3.85%
Cash From Operating Activities $2.180M -$740.0K -$2.320M
YoY Change -193.97% -125.87% -537.74%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$100.0K -$80.00K
YoY Change -50.0% 150.0% -86.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$40.00K -$100.0K -$80.00K
YoY Change -50.0% 150.0% -81.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -810.0K -890.0K -810.0K
YoY Change 0.0% 7.23%
NET CHANGE
Cash From Operating Activities 2.180M -740.0K -2.320M
Cash From Investing Activities -40.00K -100.0K -80.00K
Cash From Financing Activities -810.0K -890.0K -810.0K
Net Change In Cash 1.330M -1.730M -3.210M
YoY Change -141.43% -186.93% -3666.67%
FREE CASH FLOW
Cash From Operating Activities $2.180M -$740.0K -$2.320M
Capital Expenditures -$40.00K -$100.0K -$80.00K
Free Cash Flow $2.220M -$640.0K -$2.240M
YoY Change -199.11% -122.07% -298.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-29
CY2014Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
336000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9309000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4730000
CY2014Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
21800000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2583000
crws Advanceson Factoring Agreements
AdvancesonFactoringAgreements
0
CY2014 crws Advanceson Factoring Agreements
AdvancesonFactoringAgreements
0
crws Aftertax Reduction To Net Income Amount
AftertaxReductionToNetIncomeAmount
530000
crws Aftertax Reduction To Net Income Diluted Per Share
AftertaxReductionToNetIncomeDilutedPerShare
0.05
crws Contractual Term
ContractualTerm
P10Y
crws Contractual Term
ContractualTerm
P10Y
crws Daily Cash Balance Interest Rate Stated Percentage
DailyCashBalanceInterestRateStatedPercentage
0.0125
CY2014Q4 crws Due From Factor
DueFromFactor
19248000
CY2014Q1 crws Due From Factor
DueFromFactor
20800000
crws Forfeiture Rate
ForfeitureRate
0.05
crws Forfeiture Rate
ForfeitureRate
0.05
crws Grant Date
GrantDate
2014-06-18
crws Grant Date
GrantDate
2013-06-14
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
912000
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
691000
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
787000
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2405000
CY2014Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1139000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3445000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
47162000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3229000
dei Amendment Flag
AmendmentFlag
false
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48292000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2014-12-28
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000025895
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10063600
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
CROWN CRAFTS INC
CY2014Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
805000
CY2014Q4 us-gaap Advertising Expense
AdvertisingExpense
376000
CY2013Q4 us-gaap Advertising Expense
AdvertisingExpense
213000
us-gaap Advertising Expense
AdvertisingExpense
842000
us-gaap Advertising Expense
AdvertisingExpense
655000
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
225000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
652000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
487000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
978000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
718000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
559000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
563000
CY2014Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
182000
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194000
CY2014Q4 us-gaap Assets
Assets
53099000
CY2014Q1 us-gaap Assets
Assets
46215000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
45501000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
38069000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
560000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
340000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
485000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3771000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-75000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3431000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
789000
CY2014Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
-805000
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12020302
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11794070
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
120000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
118000
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
17115000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
14665000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
43132000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
41108000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
108000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-379000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
728000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
799000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1072000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1109000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
231000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
225000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2263000
CY2013Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
-789000
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1673000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2426000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
759000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P246D
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
172000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
68000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
42000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
9000
CY2014Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
5411000
CY2014Q1 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
5411000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8335000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7776000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13024000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13024000
us-gaap Fiscal Period
FiscalPeriod
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Fiscal Year:</div> The Company&#x2019;s fiscal year ends on the Sunday that is nearest to or on March 31. References herein to &#x201c;fiscal year 2015&#x201d; or &#x201c;2015&#x201d; represent the 52-week period ending March 29, 2015 and references herein to &#x201c;fiscal year 2014&#x201d; or &#x201c;2014&#x201d; represent the 52-week period ended March 30, 2014.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
755000
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
738000
CY2014Q1 us-gaap Goodwill
Goodwill
1126000
CY2014Q4 us-gaap Goodwill
Goodwill
1126000
CY2014Q1 us-gaap Goodwill Gross
GoodwillGross
24000000
CY2014Q4 us-gaap Goodwill Gross
GoodwillGross
24000000
CY2014Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
22900000
CY2014Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
22900000
CY2014Q4 us-gaap Gross Profit
GrossProfit
6628000
CY2013Q4 us-gaap Gross Profit
GrossProfit
5954000
us-gaap Gross Profit
GrossProfit
16756000
us-gaap Gross Profit
GrossProfit
16175000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3242000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2869000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5690000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6006000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1196000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1090000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2111000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2323000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2814000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4580000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2243000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
120000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4450000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5694000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6310000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
520000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1219000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
56000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1765000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
274000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4689000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5248000
CY2014Q4 us-gaap Interest Expense
InterestExpense
10000
CY2013Q4 us-gaap Interest Expense
InterestExpense
8000
us-gaap Interest Expense
InterestExpense
27000
us-gaap Interest Expense
InterestExpense
38000
us-gaap Interest Paid Net
InterestPaidNet
10000
us-gaap Interest Paid Net
InterestPaidNet
26000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19238000
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13560000
CY2014Q4 us-gaap Inventory Net
InventoryNet
19301000
CY2014Q1 us-gaap Inventory Net
InventoryNet
13607000
CY2014Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
63000
CY2014Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
47000
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
230000
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
213000
CY2014Q4 us-gaap Legal Fees
LegalFees
59000
CY2013Q4 us-gaap Legal Fees
LegalFees
144000
us-gaap Legal Fees
LegalFees
1360000
us-gaap Legal Fees
LegalFees
701000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10298000
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2013Q4 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
8000
CY2014Q4 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
8000
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
25000
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
32000
CY2014Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
26000000
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.00125
CY2014Q3 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
-850000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2803000
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2671000
CY2014Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53099000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46215000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15059000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2446000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2446000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-223000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2594000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5957000
us-gaap Net Income Loss
NetIncomeLoss
3579000
us-gaap Net Income Loss
NetIncomeLoss
3743000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
2046000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
1779000
CY2014Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3272000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2859000
us-gaap Operating Income Loss
OperatingIncomeLoss
5731000
us-gaap Operating Income Loss
OperatingIncomeLoss
6028000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
176000
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
91000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
133000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77000
CY2014Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
7613000
CY2014Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
7613000
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2014Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
3297000
CY2013Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
2951000
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
9665000
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
9446000
CY2014Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
850000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
173000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
331000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2399000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2362000
CY2014Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5000
CY2013Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
24000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
16000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3156000
CY2014Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1391000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Reclassifications:</div><div style="display: inline; font-style: italic;"> </div>The Company has reclassified certain prior year information to conform to the amounts presented in the current year. None of the changes impact the Company&#x2019;s previously reported financial position or results of operations.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
58000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
205000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6106000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
9947000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-6106000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-9947000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4023000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3815000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
578000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
586000
CY2014Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
235000
CY2014Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
193000
CY2013Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74000
CY2014Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2052000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3216000
us-gaap Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Royalty Payments:</div> The Company has entered into agreements that provide for royalty payments based on a percentage of sales with certain minimum guaranteed amounts. These royalties are accrued based upon historical sales rates adjusted for current sales trends by customers. Royalty expense is included in cost of sales in the accompanying unaudited consolidated statements of income and amounted to $2.5 million and $1.9 million for the three-month periods ended December 28, 2014 and December 29, 2013, respectively, and $5.9 million and $5.3 million for the nine-month periods ended December 28, 2014 and December 29, 2013, respectively.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2014Q4 us-gaap Royalty Expense
RoyaltyExpense
2500000
CY2013Q4 us-gaap Royalty Expense
RoyaltyExpense
1900000
us-gaap Royalty Expense
RoyaltyExpense
5900000
us-gaap Royalty Expense
RoyaltyExpense
5300000
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
23743000
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
20619000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
59888000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
57283000
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
23743000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
20619000
us-gaap Sales Revenue Net
SalesRevenueNet
59888000
us-gaap Sales Revenue Net
SalesRevenueNet
57283000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
185000
us-gaap Share Based Compensation
ShareBasedCompensation
652000
us-gaap Share Based Compensation
ShareBasedCompensation
487000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
28000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
28000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
42000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
30000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.97
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.67
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.62
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.44
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.90
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
6.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0405
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0521
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0095
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0049
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
125000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
55000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.60
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.14
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
23000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
60000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
340000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
145000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
340000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
205000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.76
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.23
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.80
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.70
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.78
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.12
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.90
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
262000
us-gaap Stock Issued1
StockIssued1
354000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
40000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
38040000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
35917000
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1956702
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1932744
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8320000
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
8147000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Use of Estimates: </div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying consolidated balance sheets and the reported amounts of revenues and expenses during the periods presented on the accompanying consolidated statements of income and cash flows. Significant estimates are made with respect to the allowances related to accounts receivable for customer deductions for returns, allowances and disputes. The Company also has a certain amount of discontinued finished goods which necessitates the establishment of inventory reserves and allocates indirect costs to inventory based on an estimated percentage of the supplier purchase price, each of which is highly subjective. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2014Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
30
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
18
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
35
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10102
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9877
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10076
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9858
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10072
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9859
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10041
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9845

Files In Submission

Name View Source Status
0001437749-15-002331-index-headers.html Edgar Link pending
0001437749-15-002331-index.html Edgar Link pending
0001437749-15-002331.txt Edgar Link pending
0001437749-15-002331-xbrl.zip Edgar Link pending
crws-20141228.xml Edgar Link completed
crws-20141228.xsd Edgar Link pending
crws-20141228_cal.xml Edgar Link unprocessable
crws-20141228_def.xml Edgar Link unprocessable
crws-20141228_lab.xml Edgar Link unprocessable
crws-20141228_pre.xml Edgar Link unprocessable
crws20141228_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending